Halozyme Therapeutics, a biopharmaceutical company is engaged in the development and commercialization of products targeting the extracellular matrix for the drug delivery, oncology, dermatology and endocrinology markets. Its products portfolio depends on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes affecting the extracellular matrix. The company's Enhanze technology is a novel drug delivery platform proposed to enhance the absorption and dispersion of biologics.

Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Halozyme Therapeutics. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.

Scope

The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

A quick "one-stop-shop" to understand the company.
Enhance business/sales activities by understanding customers' businesses better.
Get detailed information and financial & strategic analysis on companies operating in your industry.
Identify prospective partners and suppliers - with key data on their businesses and locations.
Capitalize on competitors' weaknesses and target the market opportunities available to them.
Compare your company's financial trends with those of your peers / competitors.
Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Key Information
Key Ratios
Share Data
Performance Chart
List of Tables
List of Figures
- Key Facts
- Business Description
- Major Products and Services
- Overview
- History
- SWOT Analysis Overview
- Overview
- Halozyme Therapeutics - Strengths
- Proprietary Enhanze Technology
- Focused Research and Development Activities
- Collaborative Agreements
- Halozyme Therapeutics - Weaknesses
- Increasing Operating Losses
- Halozyme Therapeutics - Opportunities
- Chemophase- Lead Product Candidate
- Extensive Portfolio of Product Candidates
- Rising Healthcare Expenditure in the US
- Halozyme Therapeutics - Threats
- Changing Political Climate in the US
- Tightening of FDA's Regulatory Oversight
- Industry Consolidation
- Key Competitors
- Key Employees
- Key Employee Biographies
- Locations And Subsidiaries
- Head Office
- Financial Ratios
- Capital Market Ratios
- Annual Ratios
- Interim Ratios
- Ratio Charts
- Appendix
- Methodology
- Ratio Definitions
- About Global Markets Direct
- Contact Us
- Disclaimer
List of Tables
- Halozyme Therapeutics, Key Facts
- Halozyme Therapeutics, Key Ratios
- Halozyme Therapeutics, Share Data
- Halozyme Therapeutics, Key Facts
- Major Products and Services
- Halozyme Therapeutics, History
- Halozyme Therapeutics, Key Employees
- Halozyme Therapeutics, Key Employee Biographies
- Halozyme Therapeutics, Ratios based on current share price
- Halozyme Therapeutics, Annual Ratios
- Halozyme Therapeutics, Interim Ratios
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
List of Figures
- Halozyme Therapeutics, Performance Chart (2004 - 2008)
- Halozyme Therapeutics, Ratio Charts

Pharmaceutical Market Research

Halozyme Therapeutics - Financial and Strategic Analysis Review